Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Daniela Di Mauro"'
Autor:
Marco Meazza Prina, Francesca Martini, Federico Bracchi, Daniela Di Mauro, Anna Fargnoli, Marco Motta, Cristina Giussani, Giovanni Gobbin, Monica Taverna, Andrea D’Alessio
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-5 (2021)
Abstract Background Hemophagocytic syndrome (HPS) is a severe hyperinflammatory disease, whose diagnosis is based on the HLH-2004 criteria. In secondary forms of HLH (sHLH), the primary goal is treating the triggering factors such as COVID-19 (Corona
Externí odkaz:
https://doaj.org/article/713f3170431f4054932b1cb64f42d4d9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anna Fargnoli, Daniela Di Mauro, Marco Meazza Prina, Giovanni Gobbin, Andrea D'Alessio, Cristina Giussani, Marco Motta, Francesca Martini, Monica Taverna, Federico Bracchi
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 3935, p 3935 (2020)
Volume 9
Issue 12
Journal of Clinical Medicine, Vol 9, Iss 3935, p 3935 (2020)
Volume 9
Issue 12
Background The use of computed tomography (CT) for coronavirus disease 2019 (COVID-19) diagnosis in an area of northern Italy with a high incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may have identified more pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::119bfcdf3cd9f5cab24e85c315dc1192
http://europepmc.org/articles/PMC7761962
http://europepmc.org/articles/PMC7761962
Autor:
Daniela Di Mauro, Giovanni Gobbin, Francesca Martini, Marco Meazza Prina, Cristina Giussani, Anna Fargnoli, Andrea D'Alessio, Marco Motta, Monica Taverna, Federico Bracchi
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-5 (2021)
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-5 (2021)
Background Hemophagocytic syndrome (HPS) is a severe hyperinflammatory disease, whose diagnosis is based on the HLH-2004 criteria. In secondary forms of HLH (sHLH), the primary goal is treating the triggering factors such as COVID-19 (Coronavirus dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70de52ac2b821e522208bb6f3412ff19
https://pubmed.ncbi.nlm.nih.gov/34388982
https://pubmed.ncbi.nlm.nih.gov/34388982
Autor:
Marco Meazza Prina, Federico Bracchi, Marco Motta, Monica Taverna, Giovanni Gobbin, Anna Fargnoli, Cristina Giussani, Francesca Martini, Daniela Di Mauro, Andrea D'Alessio
Background The acknowledgment of computed tomography (CT) defined diagnosis in high prevalence northern Italy may identify more patients with Coronavirus Disease-2019 (COVID 19) infection, than RT-PCR alone. Methods We retrospectively reviewed 148 ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd81fdc2ef0d87c534e56ddee74c6af9
https://doi.org/10.20944/preprints202009.0075.v1
https://doi.org/10.20944/preprints202009.0075.v1
Autor:
Anna Falanga, Andrea D'Alessio, Kim W.F.M. Lambregts, Laura Russo, Sara Cecchini, Marina Marchetti, Daniela Di Mauro, Carmen J Tartari
Publikováno v:
Cancer Investigation. 35:490-499
We enrolled 62 consecutive patients with advanced stage cancers and venous thromboembolism (VTE), prospectively followed until 1 year. All patients received 6 month low-molecular-weight heparin (LMWH) therapy. We evaluated thrombin generation (TG) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87d39ee77b0b07d7c141d58ae05e5979
https://doi.org/10.1080/07357907.2017.1340480
https://doi.org/10.1080/07357907.2017.1340480
Autor:
Daniela Di Mauro, Andrea D'Alessio, Davide Resta, Carmelo Fortugno, Simonetta Villa, Luca Geroli, S. Cecchini, Antonello Quadri
Publikováno v:
Tumori Journal. 102:S65-S68
Purpose Cetuximab and panitumumab are monoclonal antibody inhibitors that bind the epidermal growth factor receptor (EGFR) currently used in the treatment of metastatic colorectal cancer. The main adverse event related to EGFR inhibitors (EGFR-Is) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f2eba71793a3d621c5f83af0db0226f
https://doi.org/10.5301/tj.5000579
https://doi.org/10.5301/tj.5000579